🌐Purchase Tagrisso Osimertinib 80 mg Tablets Online USA, UK, UAE Australia, Europe, Cambridge, London, Morocco, Indonesia, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, United Arab Emirates, South Korea, Africa, Thailand, Vietnam, Middle East, and Southeast Asian countries.

Tagrisso Osimertinib 80 mg Tablets

Tagrisso (Osimertinib 80 mg) is a targeted anti-cancer medication used primarily in the treatment of non-small cell lung cancer (NSCLC). It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), specifically designed to target and block the activity of the epidermal growth factor receptor (EGFR) mutations responsible for cancer cell growth.

Osimertinib is especially effective in patients who have EGFR T790M mutation-positive lung cancer, including those who have developed resistance to earlier EGFR therapies. It works by selectively inhibiting cancer cell growth while minimizing damage to healthy cells, making it a highly advanced and preferred treatment option.

📞 Contact Details to Place Order

💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
🌐 Website: https://globmedindia.com

Composition and Content

Active Ingredient: Osimertinib Mesylate
Strength: Equivalent to 80 mg Osimertinib
Form: Oral Tablets
Class: EGFR Tyrosine Kinase Inhibitor (Third-generation)

How to Use

Take one tablet daily, preferably at the same time each day.
Swallow whole with water; do not crush or chew.
Can be taken with or without food.
Follow your oncologist’s instructions strictly.

Dosage

Standard Dose: 80 mg once daily
Dose adjustments may be required based on:
- Patient tolerance
- Side effects
- Liver or kidney function

Uses

Tagrisso is used for:

Treatment of EGFR mutation-positive NSCLC
Patients with T790M mutation-positive lung cancer
First-line treatment for advanced/metastatic NSCLC
Adjuvant therapy after tumor removal in certain cases

Treatments & Mechanism

Targets and blocks EGFR mutations
Prevents tumor growth and spread
Effective even in resistant cancer cases
Improves progression-free survival and overall survival rates

Advantages

Highly targeted therapy with fewer side effects than chemotherapy
Effective against drug-resistant cancer mutations
Oral administration (no hospitalization required)
Better quality of life for patients
Proven high efficacy in advanced lung cancer

Storage Conditions

Store below 30°C
Keep in a dry and cool place
Protect from direct sunlight and moisture
Keep out of reach of children

Alternative Indian Brands for Osimertinib 80 mg

Some commonly available alternatives include:

Osimert (by Everest Pharma)
Osicent (by Incepta Pharmaceuticals)
Tagrix (by Beacon Pharmaceuticals)
Osimertinib (generic versions by Indian manufacturers like Natco, Hetero, etc.)

(Always consult a doctor before switching brands.)